1. Home
  2. EH vs CSTL Comparison

EH vs CSTL Comparison

Compare EH & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$11.17

Market Cap

866.0M

Sector

Industrials

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$25.60

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EH
CSTL
Founded
2014
2007
Country
China
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
866.0M
806.3M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
EH
CSTL
Price
$11.17
$25.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$21.85
$47.17
AVG Volume (30 Days)
499.0K
395.2K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
$10.53
$2.10
Revenue Next Year
$81.37
$12.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$11.07
$14.59
52 Week High
$23.44
$44.28

Technical Indicators

Market Signals
Indicator
EH
CSTL
Relative Strength Index (RSI) 38.87 28.37
Support Level $11.15 $21.77
Resistance Level $12.80 $34.97
Average True Range (ATR) 0.58 1.23
MACD 0.01 0.08
Stochastic Oscillator 6.35 12.13

Price Performance

Historical Comparison
EH
CSTL

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: